Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.82% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.26% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
CALL
Vertex Pharmaceuticals
VRTX
$131B
| $119M | 0.03% |
421,100
+149,100
| +55% | +$39.9M |
|
477
CALL
McKesson
MCK
$100B
| $118M | 0.03% |
363,100
+62,500
| +21% | +$20M |
|
|
EA
478
CALL
DELISTED
Electronic Arts
EA
| $118M | 0.03% |
972,000
+317,300
| +48% | +$40.5M |
|
479
FedEx
FDX
$80.4B
| $118M | 0.03% |
521,284
-403,525
| -44% | -$86.1M |
|
480
CALL
Shell
SHEL
$249B
| $118M | 0.03% |
2,250,600
+648,600
| +40% | +$36.4M |
|
481
CME Group
CME
$96.1B
| $118M | 0.03% |
574,335
+68,126
| +13% | +$14.4M |
|
482
Ametek
AME
$58.7B
| $117M | 0.03% |
1,068,025
-618,856
| -37% | -$75.2M |
|
483
CALL
Dow Inc
DOW
$21.9B
| $117M | 0.03% |
2,273,400
-16,200
| -0.7% | -$1.04M |
|
484
Gaming and Leisure Properties
GLPI
$12.7B
| $117M | 0.03% |
2,554,501
+2,407,955
| +1,643% | +$110M |
|
485
CALL
ProShares UltraPro QQQ
TQQQ
$38.7B
| $117M | 0.03% |
9,747,600
+4,786,200
| +96% | +$84.9M |
|
486
Seagate
STX
$209B
| $117M | 0.03% |
1,635,774
+1,610,484
| +6,368% | +$131M |
|
487
Altria Group
MO
$109B
| $116M | 0.03% |
2,789,000
-1,119,326
| -29% | -$58M |
|
488
PUT
NextEra Energy
NEE
$179B
| $116M | 0.03% |
1,502,800
+235,100
| +19% | +$17.9M |
|
489
PUT
JD.com
JD
$39.5B
| $116M | 0.03% |
1,799,800
-627,800
| -26% | -$36.2M |
|
490
CALL
Align Technology
ALGN
$12.5B
| $115M | 0.03% |
487,800
-231,000
| -32% | -$71M |
|
491
PUT
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$141M
| $115M | 0.03% |
312,000
-450,236
| -59% | -$178M |
|
492
PUT
Expedia Group
EXPE
$39.4B
| $115M | 0.03% |
1,211,800
+324,000
| +36% | +$45.9M |
|
493
CALL
iShares Core S&P 500 ETF
IVV
$910B
| $114M | 0.03% |
301,800
+157,600
| +109% | +$64.8M |
|
494
LyondellBasell Industries
LYB
$20.2B
| $114M | 0.03% |
1,307,997
+819,399
| +168% | +$85.4M |
|
495
CALL
SLB Ltd
SLB
$77.1B
| $114M | 0.03% |
3,193,400
+1,043,600
| +49% | +$43.5M |
|
496
CALL
Constellation Brands
STZ
$23.3B
| $114M | 0.03% |
489,000
+25,000
| +5% | +$6.08M |
|
497
Dominion Energy
D
$60.3B
| $114M | 0.03% |
1,427,408
+1,180,301
| +478% | +$97.5M |
|
498
CALL
Cummins
CMI
$86.9B
| $114M | 0.03% |
587,700
+252,900
| +76% | +$50.6M |
|
499
PUT
Marriott International
MAR
$91.9B
| $113M | 0.03% |
833,100
+12,000
| +1% | +$1.98M |
|
500
PUT
SolarEdge
SEDG
$1.98B
| $113M | 0.03% |
413,400
+29,300
| +8% | +$8.01M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.